Locations:
November 28, 2022/News Updates

Cleveland Clinic Announces Update on Cole Eye Institute Expansion

Project includes transition to new building entrance and traffic pattern changes

Media Contact

Katie Ely | 216.906.5597

Cole_Northeast Rendering

To support Cleveland Clinic’s Cole Eye Institute renovation and expansion, changes will be made to the entrance and traffic pattern used by patients to access the Cole Eye building.

The main entrance to the Cole Eye building located on Cole Drive via E. 105th Street will close on Saturday, Dec. 3, 2022, as construction begins on the project.

The temporary new entrance will be located at the east-side entrance of the Crile Building at 2042 E. 102nd Street. Valet services for Cole Eye will be located at this entrance Monday – Friday (6 a.m. – 6 p.m.).

Additional support and signage will be in place to help patients navigate to their appointments. Patients are asked to allow for additional travel time during construction.

Cole Eye Institute is one of the world’s most advanced eye centers. The expanded eye center will enable Cleveland Clinic to provide the best patient experience and improve the delivery of treatment for eye diseases. The new building and renovated facilities will allow Cleveland Clinic to serve more patients in need of eye care.

The expansion is expected to be complete at the end of 2025. Patient care will continue during construction.

Click here for additional details on the project and construction updates.

Latest from the Newsroom

Cleveland Clinic's new teaching kitchen and food pantry at the Langston Hughes Community Health & Education Center

Cleveland Clinic Opens Teaching Kitchen and Food Pantry on Cleveland's East Side

VeloSano riders

$20.2 Million Raised for VeloSano, Funding Cancer Research at Cleveland Clinic in 2026

Photo of spine imaging.

Cleveland Clinic Expands Orthopaedic Care in the Mahoning Valley Through Acquisition of Youngstown Orthopaedic Associates Practice

Lobby of new Toronto location

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Artist's rendering of gene therapy for high triglycerides.

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

Artist's illustration of gene editing

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

Medical illustration of lipoprotein(a) molecule

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years

Ali Aminian, M.D., performing bariatric surgery.

Cleveland Clinic Study Finds Bariatric Surgery Effective for Substantial Weight Loss After GLP-1 Intolerance or Limited Weight Loss